Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

about

Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

Item

http://www.wikidata.org/entity/Q50026330

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

@en

Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

@nl

type

Item

label

Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

@en

Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

@nl

prefLabel

Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

@en

Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

@nl

P1476

Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.

@en

P2093

Fan Ping

http://www.w3.org/2001/XMLSchema#string

Jia Zheng

http://www.w3.org/2001/XMLSchema#string

Miao Yu

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

Qian Zhang

http://www.w3.org/2001/XMLSchema#string

Tong Wang

http://www.w3.org/2001/XMLSchema#string

Xiaojing Wang

http://www.w3.org/2001/XMLSchema#string

Xinhua Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase

Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

The role of ANGPTL3 in controlling lipoprotein metabolism

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus

Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases

P31

scholarly article

P356

10.1042/BSR20180059

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29440457

http://www.w3.org/2001/XMLSchema#string

P932

5857913

http://www.w3.org/2001/XMLSchema#string